↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$65.2MSold on the market
1Companies
Aug 17, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 202617:30 | Aug 14, 2026from Aug 13, 2026 | DYNDyne Therapeutics, Inc. | Director | S · Sell10b5-1 | $25.20 | −2,586,928 | 428,946 | -86% | −$65.2M |